SE, J., E, V., BA, C., AN, M., TK, B., DE, M., . . . AL, N. (2023). Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial. JAMA network open, 6(7), e2322131. https://doi.org/10.1001/jamanetworkopen.2023.22131
Chicago Style (17th ed.) CitationSE, Juul, Voldal E, Comstock BA, Massaro AN, Bammler TK, Mayock DE, Heagerty PJ, Wu YW, and Numis AL. "Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial." JAMA Network Open 6, no. 7 (2023): e2322131. https://doi.org/10.1001/jamanetworkopen.2023.22131.
MLA (9th ed.) CitationSE, Juul, et al. "Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial." JAMA Network Open, vol. 6, no. 7, 2023, p. e2322131, https://doi.org/10.1001/jamanetworkopen.2023.22131.